Global Competitive & Strategic Intelligence Director Rare Disease (Maternity Cover starting in [...]

Ipsen Biopharm Ltd; London; On-site; GBP 80,000 - 120,000; Full time

Job summary

Ipsen Biopharm Ltd is seeking a Global Competitive & Strategic Intelligence Director for a 12-month maternity cover. This role involves leading competitive insights initiatives in rare diseases, supporting strategic decision-making, and requires 7+ years of experience in biopharma. The ideal candidate will possess strong analytical skills and familiarity with Ipsen’s therapeutic areas.

Qualifications

• 7+ years in biopharma, healthcare, or related fields.
• Experience in strategic CI, drug development, and commercialization.
• Fluency in English.

Responsibilities

• Develop CSI operating plans and prioritize analyses.
• Conduct secondary research on competitive threats.
• Manage external CI firms for research.

Skills

Analytical skills

Communication skills

Strategic competitive intelligence

Education

Advanced degrees (PhD, MD, MBA)

Job description

Below is a refined version of the job description, with improved formatting and focus:

Global Competitive & Strategic Intelligence Director Rare Disease (Maternity Cover starting in July 2025)

Company: Ipsen Biopharm Ltd

About Ipsen: Ipsen is a mid-sized global biopharmaceutical company focused on transformative medicines in Oncology, Rare Disease, and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France, and the U.K, we address areas of high unmet medical need through research and innovation. Our teams in over 40 countries are dedicated to bringing medicines to patients in 88 countries. We foster a culture of collaboration, excellence, and impact, empowering individuals to grow and thrive. Join us on our journey towards sustainable growth and creating real impact on patients and society. More info at https://www.ipsen.com/.

Position Summary & Purpose

The CSI team supports Ipsen’s portfolio and growth by providing competitive insights to facilitate faster, better decision-making. This role leads CI initiatives in specific therapeutic areas, acting as a strategic partner to asset teams and leadership, supporting enterprise CI initiatives aligned with the Global Head of CSI. It is a 12-month secondment supporting rare disease assets.

Main Responsibilities & Technical Competencies

• Develop CSI operating plans, identify key threats, and prioritize analyses based on program strategy.
• Conduct secondary research on competitive threats, providing timely insights to leadership.
• Maintain and update competitive landscapes, timelines, and catalyst trackers.
• Manage external CI firms for primary and secondary research.
• Create strategic analyses (e.g., Porter's 5 Forces, SWOT, scenario planning).
• Organize cross-functional competitive simulations and responses.
• Update asset teams on competitive activities and implications.
• Ensure comprehensive CI coverage at key congresses and events.
• Leverage AI tools to enhance CI research and outputs.
• Build strong relationships with internal stakeholders and external CI providers.

Knowledge & Experience

Essential: 7+ years in biopharma, healthcare, or related fields; experience in strategic CI, drug development, and commercialization; strong analytical and communication skills; familiarity with Ipsen’s therapeutic areas preferred; fluency in English.

Preferred: Knowledge of clinical data, regulatory frameworks, and launch strategies; advanced degrees (PhD, MD, MBA).

Equality Statement

Ipsen is committed to diversity and encourages applications from all backgrounds.